Literature DB >> 17642890

Utility of polymerase chain reaction as a diagnostic tool in cutaneous tuberculosis.

L Padmavathy1, L Rao, A Veliath.   

Abstract

BACKGROUND: Differentiation of cutaneous tuberculosis from other infective granulomas of the skin is difficult due to paucity of the organisms in tissue biopsies. Polymerase chain reaction (PCR) is a newer technique to identify the DNA of Mycobacterium tuberculosis in the tissues. AIM: We examined the utility of PCR as a tool for rapid diagnosis of cutaneous tuberculosis especially in cases negative by ZN staining and culture.
MATERIAL AND METHODS: Twenty five random skin biopsies from patients with various types of cutaneous tuberculosis were subjected to PCR.
RESULTS: An overall positivity of 64% was observed, which is comparable to other series. Seventy five percent of lupus vulgaris cases, 62.2% of tuberculosis verrucosa cutis and 50% of scrofuloderma cases showed PCR positivity.
CONCLUSION: Though useful, the cost and the technique involved limit the use of PCR in developing countries like ours.

Entities:  

Year:  2003        PMID: 17642890

Source DB:  PubMed          Journal:  Indian J Dermatol Venereol Leprol        ISSN: 0378-6323            Impact factor:   2.545


  3 in total

1.  Lewandowsky's Rosaceiform Eruption: a Form of Cutaneous Tuberculosis Confirmed by PCR in Two Patients.

Authors:  Rodrigo Conlledo; Antonio Guglielmetti; Macarena Sobarzo; Francisca Woolvett; Francisca Bravo; Sergio González; Félix Fich; Verónica Vial
Journal:  Dermatol Ther (Heidelb)       Date:  2014-12-18

Review 2.  Effectiveness of real-time polymerase chain reaction assay for the detection of Mycobacterium tuberculosis in pathological samples: a systematic review and meta-analysis.

Authors:  Emmanuel O Babafemi; Benny P Cherian; Lee Banting; Graham A Mills; Kandala Ngianga
Journal:  Syst Rev       Date:  2017-10-25

3.  Separation of Mycobacterium smegmatis From a Mixed Culture Using the Cell Wall Binding Domain of D29 Mycobacteriophage Endolysin.

Authors:  Gokul Nair; Vikas Jain
Journal:  Front Microbiol       Date:  2020-06-05       Impact factor: 6.064

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.